AI assistant
Enlight Energy — Director's Dealing 2026
May 28, 2026
6777_rns_2026-05-28_3e6dabcd-97f7-407a-bf59-127ef85ee95a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| OMB APPROVAL | |
|---|---|
| OMB Number: | 3235-0287 |
| Estimated average burden hours per response | 0.5 |
☐ Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
| 1. Name and Address of Reporting Person* Carr Meron (Last) (First) (Middle) C/O ENLIGHT RENEWABLE ENERGY LTD. 13 AMAL ST. AFEK INDUSTRIAL PARK (Street) ROSH HAAYIN 4809249 (City) (State) (Zip/Postal Code) ISRAEL (Country) | 2. Issuer Name and Ticker or Trading Symbol Enlight Renewable Energy Ltd. [ ENLT ] 2a. Foreign Trading Symbol ENLT 3. Date of Earliest Transaction (Month/Day/Year) 05/27/2026 4. If Amendment, Date of Original Filed (Month/Day/Year) | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP, STRATEGIC PROJECTS 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person | |
|---|---|---|---|
| Table I – Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | |||
| --- | --- | --- | --- |
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) |
| Code | |||
| Ordinary shares, NIS 0.1 par value per share | 05/27/2026 | M | |
| Ordinary shares, NIS 0.1 par value per share | 05/27/2026 | F | |
| Ordinary shares, NIS 0.1 par value per share | 05/27/2026 | S | 3,074 | D | $103.88(4) | 42,465(2) | D | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary shares, NIS 0.1 par value per share | 05/28/2026 | M | 4,425 | A | $23.22(1) | 46,890(2) | D | |||
| Ordinary shares, NIS 0.1 par value per share | 05/28/2026 | F | 1,096(3) | D | $103.44(5) | 45,794(2) | D | |||
| Ordinary shares, NIS 0.1 par value per share | 05/28/2026 | S | 3,329 | D | $103.44(5) | 42,465(2) | D | |||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Table II – Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | ||||||||||
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | |||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | ||||
| Stock Options (right to buy) | $23.22(1) | 05/27/2026 | M | 4,075 | (6) | 09/30/2028 | Ordinary shares, NIS 0.1 par value per share | |||
| Stock Options (right to buy) | $23.22(1) | 05/28/2026 | M | 4,425 | (6) | 09/30/2028 | Ordinary shares, NIS 0.1 par value per share | |||
| Stock Options (right to buy) | $27.33(7) | (8) | 10/01/2032 | Ordinary shares, NIS 0.1 par value per share |
Explanation of Responses:
1. Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
2. Includes (i) 11,365 restricted share units granted on April 21, 2024, with 5,682 vesting on April 21, 2027 and 5,683 vesting on April 21, 2028; and (ii) 19,736 restricted share units granted on October 1, 2025, with 4,934 vesting on each of October 1, 2026, October 1, 2027, October 1, 2028, and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.
3. These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.
-
Represents a transaction price of NIS 296.99, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.859 as of the date immediately preceding the date of the transaction.
-
Represents a transaction price of NIS 293.78, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.840 as of the date immediately preceding the date of the transaction.
-
Stock options were granted on September 30, 2021, with each having vested on September 30, 2025.
-
Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.
-
Stock options were granted on October 1, 2025, with 22,441 vesting on October 1, 2026, and 22,442 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.
-
No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
/s/ Helit Megido as attorney-in-fact for Meron Carr 05/28/2026
** Signature of Reporting Person
Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
- If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.